Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10-K
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
News
TYPE
HEADLINE
FILED AT
8-K
Marker Therapeutics Awarded $2.6 Million FDA Orphan Products Development Grant to Advance MT-601 in Pancreatic Cancer
8-K
Marker Therapeutics, Inc. Announces Results of 2026 Annual Meeting of Stockholders
8-K
Marker Therapeutics Reports Year-End 2025 Corporate and Financial Results
8-K
Marker Therapeutics Schedules 2026 Annual Meeting of Stockholders
8-K
Marker Therapeutics Reports Q3 2025 Results; MT-601 APOLLO data and RAPID Off-the-Shelf program progress; manufacturing collaboration with Cellipont; ATM financ
8-K
Marker Therapeutics appoints Kathryn Penkus Corzo to Board of Directors
